Merck Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Merck Company
MRK Stock  USD 110.53  0.46  0.41%   
Analyzing historical trends in various income statement and balance sheet accounts from Merck's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck's valuation are summarized below:
Gross Profit
50 B
Profit Margin
0.2963
Market Capitalization
277.2 B
Enterprise Value Revenue
4.5568
Revenue
64.2 B
There are currently one hundred twenty fundamental ratios for Merck that can be evaluated and compared over time across peers in the industry. We recommend to check Merck's last-minute fundamental drivers against the all of the trends between 2010 and 2026. Market Cap is expected to rise to about 178.5 B this year. Enterprise Value is expected to rise to about 194.7 B this year

Merck Total Revenue

77.48 Billion

Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 B, Interest Expense of 1.5 B or Total Revenue of 77.5 B, as well as many indicators such as Price To Sales Ratio of 4.53, Dividend Yield of 0.0238 or PTB Ratio of 6.9. Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
Build AI portfolio with Merck Stock
Check out the analysis of Merck Correlation against competitors.

Merck Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets141.4 B134.7 B98.7 B
Slightly volatile
Short and Long Term Debt Total46.2 B44 B28.1 B
Slightly volatile
Other Current Liabilities21.1 B20.1 B13.5 B
Slightly volatile
Total Current Liabilities34.3 B32.7 B21.7 B
Slightly volatile
Total Stockholder Equity55.9 B53.3 B40.2 B
Pretty Stable
Property Plant And Equipment Net28.7 B27.3 B17 B
Slightly volatile
Retained Earnings76.2 B72.5 B47.9 B
Slightly volatile
Cash16 B15.2 B10 B
Slightly volatile
Non Current Assets Total94.6 B90.1 B67.4 B
Slightly volatile
Non Currrent Assets Other19.4 B18.5 B9.3 B
Slightly volatile
Cash And Short Term Investments16.5 B15.7 B11.9 B
Very volatile
Net Receivables12.4 B11.8 B8 B
Slightly volatile
Common Stock Shares Outstanding2.8 B2.9 B2.7 B
Slightly volatile
Liabilities And Stockholders Equity141.4 B134.7 B98.7 B
Slightly volatile
Non Current Liabilities Total51.1 B48.7 B36.4 B
Slightly volatile
Inventory3.8 B7 B5.4 B
Slightly volatile
Other Current Assets10.5 B10 B5.9 B
Slightly volatile
Total Liabilities85.4 B81.3 B58 B
Slightly volatile
Total Current Assets46.8 B44.6 B31.4 B
Slightly volatile
Short Term Debt2.3 B3.4 B3 B
Pretty Stable
Intangible Assets14.5 B18.8 B18.5 B
Pretty Stable
Accounts Payable2.8 B4.7 B3.2 B
Slightly volatile
Property Plant And Equipment Gross51.8 B49.4 B24.2 B
Slightly volatile
Common Stock Total Equity1.2 B2.1 B1.7 B
Slightly volatile
Capital Stock1.2 B2.1 B1.7 B
Slightly volatile
Common Stock1.2 B2.1 B1.7 B
Slightly volatile
Other Liabilities10.2 B10.5 B10.7 B
Pretty Stable
Other Assets93.3 B88.9 B20.3 B
Slightly volatile
Long Term Debt41.6 B39.6 B24.8 B
Slightly volatile
Good Will12.7 B24.9 B16.9 B
Slightly volatile
Property Plant Equipment17.1 B28.9 B17.2 B
Slightly volatile
Current Deferred Revenue6.6 B5.3 B2.6 B
Slightly volatile
Long Term Debt Total25.5 B39.6 B24.4 B
Slightly volatile
Capital Surpluse45.3 B51.4 B42 B
Slightly volatile
Long Term Investments395.9 M416.7 M5.1 B
Slightly volatile
Short and Long Term Debt3.1 B3 B2.4 B
Slightly volatile
Non Current Liabilities Other7.6 B5.8 B8.8 B
Very volatile
Cash And Equivalents9.7 B15.2 B8.4 B
Slightly volatile
Net Invested Capital72 B95.9 B64.9 B
Slightly volatile
Net Working Capital6.9 B11.9 B6.6 B
Slightly volatile

Merck Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.8 B5.2 B4.7 B
Slightly volatile
Total Revenue77.5 B73.8 B47.7 B
Slightly volatile
Gross Profit59.1 B56.3 B33.2 B
Slightly volatile
Other Operating Expenses53.1 B50.5 B37.2 B
Slightly volatile
Operating Income24.4 B23.3 B10.5 B
Slightly volatile
EBIT25.6 B24.4 B11.3 B
Slightly volatile
EBITDA31 B29.6 B16.1 B
Slightly volatile
Cost Of Revenue10.3 B17.5 B14.1 B
Pretty Stable
Total Operating Expenses34.7 B33.1 B22.7 B
Slightly volatile
Income Before Tax24.1 B22.9 B10.4 B
Slightly volatile
Net Income20.7 B19.7 B8.7 B
Slightly volatile
Income Tax Expense1.9 B3.2 B2 B
Pretty Stable
Research Development21.7 B20.6 B12.3 B
Slightly volatile
Selling General Administrative7.9 B8.9 B7.9 B
Pretty Stable
Net Income Applicable To Common Shares20.7 B19.7 B9.1 B
Slightly volatile
Net Income From Continuing Ops20.7 B19.7 B9.7 B
Slightly volatile
Non Recurring288.1 M303.3 M734.3 M
Slightly volatile
Selling And Marketing Expenses2.1 B2.2 B6.6 B
Slightly volatile
Tax Provision2.3 B3.2 B1.8 B
Slightly volatile
Interest Income705 M477.2 M735.7 M
Pretty Stable
Reconciled Depreciation3.2 B4 B4.2 B
Slightly volatile
Discontinued Operations563.2 M633.6 M691.6 M
Slightly volatile

Merck Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow21.9 B20.8 B10.5 B
Slightly volatile
Begin Period Cash Flow6 B7.9 B8.9 B
Pretty Stable
Depreciation3.2 B5.2 B4.7 B
Slightly volatile
Capital Expenditures2.2 B3.9 B2.7 B
Slightly volatile
Total Cash From Operating Activities25.9 B24.7 B13.3 B
Slightly volatile
Net Income20.7 B19.7 B8.8 B
Slightly volatile
End Period Cash Flow16.1 B15.3 B10 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.534.513.9155
Slightly volatile
Dividend Yield0.02380.0280.0319
Slightly volatile
PTB Ratio6.96.255.0432
Slightly volatile
Days Sales Outstanding69.9167.2363.7879
Pretty Stable
Book Value Per Share17.3116.4814.5364
Pretty Stable
Free Cash Flow Yield0.04220.06470.0532
Pretty Stable
Operating Cash Flow Per Share8.017.634.7693
Slightly volatile
Stock Based Compensation To Revenue0.00730.01070.0086
Slightly volatile
Capex To Depreciation1.350.860.7778
Slightly volatile
PB Ratio6.96.255.0432
Slightly volatile
EV To Sales3.443.884.1244
Slightly volatile
Free Cash Flow Per Share6.756.433.7418
Slightly volatile
ROIC0.150.220.1016
Slightly volatile
Inventory Turnover2.192.242.5397
Pretty Stable
Net Income Per Share6.396.083.1305
Slightly volatile
Days Of Inventory On Hand175169147
Slightly volatile
Payables Turnover3.893.354.7405
Slightly volatile
Sales General And Administrative To Revenue0.080.110.0738
Slightly volatile
Research And Ddevelopement To Revenue0.140.250.2321
Slightly volatile
Capex To Revenue0.07570.06040.0609
Slightly volatile
Cash Per Share5.114.874.2638
Pretty Stable
POCF Ratio17.9513.4915.8113
Pretty Stable
Interest Coverage12.3918.312.2716
Very volatile
Payout Ratio0.390.411.9543
Pretty Stable
Capex To Operating Cash Flow0.290.180.2383
Pretty Stable
PFCF Ratio25.6516.0121.5284
Pretty Stable
Days Payables Outstanding14211396.6049
Pretty Stable
Income Quality2.131.133.7037
Pretty Stable
ROE0.320.430.2186
Slightly volatile
EV To Operating Cash Flow18.8614.8317.189
Pretty Stable
PE Ratio12.5813.2468.4802
Pretty Stable
Return On Tangible Assets0.180.250.1328
Slightly volatile
EV To Free Cash Flow26.9417.623.4169
Pretty Stable
Earnings Yield0.05650.07810.0462
Very volatile
Intangibles To Total Assets0.220.290.3417
Very volatile
Current Ratio1.621.571.5445
Slightly volatile
Receivables Turnover4.785.625.7673
Very volatile
Graham Number49.8547.4730.0282
Slightly volatile
Shareholders Equity Per Share17.2916.4614.3594
Slightly volatile
Debt To Equity0.780.740.7056
Slightly volatile
Capex Per Share0.651.20.9916
Slightly volatile
Revenue Per Share23.9522.8117.1814
Slightly volatile
Interest Debt Per Share14.7614.0510.5032
Slightly volatile
Debt To Assets0.310.290.2704
Slightly volatile
Enterprise Value Over EBITDA10.899.714.4051
Slightly volatile
Short Term Coverage Ratios6.089.325.8502
Slightly volatile
Price Earnings Ratio12.5813.2468.4802
Pretty Stable
Operating Cycle245236211
Pretty Stable
Price Book Value Ratio6.96.255.0432
Slightly volatile
Days Of Payables Outstanding14211396.6049
Pretty Stable
Dividend Payout Ratio0.390.411.9543
Pretty Stable
Price To Operating Cash Flows Ratio17.9513.4915.8113
Pretty Stable
Price To Free Cash Flows Ratio25.6516.0121.5284
Pretty Stable
Pretax Profit Margin0.30.360.2132
Slightly volatile
Ebt Per Ebit0.90.890.9915
Pretty Stable
Operating Profit Margin0.280.360.2114
Slightly volatile
Effective Tax Rate0.320.160.2713
Very volatile
Company Equity Multiplier1.92.282.4591
Slightly volatile
Long Term Debt To Capitalization0.40.380.3587
Slightly volatile
Total Debt To Capitalization0.230.410.3841
Slightly volatile
Return On Capital Employed0.240.260.1397
Slightly volatile
Debt Equity Ratio0.780.740.7056
Slightly volatile
Ebit Per Revenue0.280.360.2114
Slightly volatile
Quick Ratio0.941.031.2187
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.612.21.4906
Pretty Stable
Net Income Per E B T0.580.770.7779
Very volatile
Cash Ratio0.340.420.4787
Slightly volatile
Cash Conversion Cycle85.0996.51127
Slightly volatile
Operating Cash Flow Sales Ratio0.220.30.2587
Slightly volatile
Days Of Inventory Outstanding175169147
Slightly volatile
Days Of Sales Outstanding69.9167.2363.7879
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.590.760.7511
Slightly volatile
Cash Flow Coverage Ratios1.280.650.6687
Pretty Stable
Price To Book Ratio6.96.255.0432
Slightly volatile
Fixed Asset Turnover2.072.432.762
Slightly volatile
Capital Expenditure Coverage Ratio3.535.734.8648
Slightly volatile
Price Cash Flow Ratio17.9513.4915.8113
Pretty Stable
Enterprise Value Multiple10.899.714.4051
Slightly volatile
Debt Ratio0.310.290.2704
Slightly volatile
Cash Flow To Debt Ratio1.280.650.6687
Pretty Stable
Price Sales Ratio4.534.513.9155
Slightly volatile
Return On Assets0.130.170.087
Slightly volatile
Asset Turnover0.680.630.5053
Slightly volatile
Net Profit Margin0.220.310.1736
Slightly volatile
Gross Profit Margin0.760.880.6921
Slightly volatile
Price Fair Value6.96.255.0432
Slightly volatile
Return On Equity0.320.430.2186
Slightly volatile

Merck Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap178.5 B170 B155.3 B
Slightly volatile
Enterprise Value194.7 B185.4 B169.4 B
Slightly volatile

Merck Fundamental Market Drivers

Forward Price Earnings11.5473
Cash And Short Term Investments13.7 B

Merck Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Merck Financial Statements

Merck investors utilize fundamental indicators, such as revenue or net income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.3 B6.6 B
Total Revenue73.8 B77.5 B
Cost Of Revenue17.5 B10.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.11  0.08 
Research And Ddevelopement To Revenue 0.25  0.14 
Capex To Revenue 0.06  0.08 
Revenue Per Share 22.81  23.95 
Ebit Per Revenue 0.36  0.28 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
How To Invest In Merck
Details
Is Merck Stock a good investment?
Details
What is Merck's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.87
Dividend Share
3.2
Earnings Share
7.56
Revenue Per Share
25.559
Quarterly Revenue Growth
0.037
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY